Transient abnormal myelopoiesis in pediatrics with trisomy 21

Transient abnormal myelopoiesis is common among Down syndrome patients. Although no therapeutic measures are required, close monitoring of comorbidities such as gastrointestinal bleeding is required. Long‐term follow‐up is promising for a healthy future and reduced requirement of unnecessary therape...

Descripción completa

Detalles Bibliográficos
Autores principales: Taee, Nadereh, Faraji‐Goodarzi, Mojgan, Safdari, Mohammad, Bajelan, Amir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869390/
https://www.ncbi.nlm.nih.gov/pubmed/33598211
http://dx.doi.org/10.1002/ccr3.3589
_version_ 1783648621961412608
author Taee, Nadereh
Faraji‐Goodarzi, Mojgan
Safdari, Mohammad
Bajelan, Amir
author_facet Taee, Nadereh
Faraji‐Goodarzi, Mojgan
Safdari, Mohammad
Bajelan, Amir
author_sort Taee, Nadereh
collection PubMed
description Transient abnormal myelopoiesis is common among Down syndrome patients. Although no therapeutic measures are required, close monitoring of comorbidities such as gastrointestinal bleeding is required. Long‐term follow‐up is promising for a healthy future and reduced requirement of unnecessary therapeutic measures including chemotherapy and remission of the pathology.
format Online
Article
Text
id pubmed-7869390
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-78693902021-02-16 Transient abnormal myelopoiesis in pediatrics with trisomy 21 Taee, Nadereh Faraji‐Goodarzi, Mojgan Safdari, Mohammad Bajelan, Amir Clin Case Rep Case Reports Transient abnormal myelopoiesis is common among Down syndrome patients. Although no therapeutic measures are required, close monitoring of comorbidities such as gastrointestinal bleeding is required. Long‐term follow‐up is promising for a healthy future and reduced requirement of unnecessary therapeutic measures including chemotherapy and remission of the pathology. John Wiley and Sons Inc. 2020-11-29 /pmc/articles/PMC7869390/ /pubmed/33598211 http://dx.doi.org/10.1002/ccr3.3589 Text en © 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Reports
Taee, Nadereh
Faraji‐Goodarzi, Mojgan
Safdari, Mohammad
Bajelan, Amir
Transient abnormal myelopoiesis in pediatrics with trisomy 21
title Transient abnormal myelopoiesis in pediatrics with trisomy 21
title_full Transient abnormal myelopoiesis in pediatrics with trisomy 21
title_fullStr Transient abnormal myelopoiesis in pediatrics with trisomy 21
title_full_unstemmed Transient abnormal myelopoiesis in pediatrics with trisomy 21
title_short Transient abnormal myelopoiesis in pediatrics with trisomy 21
title_sort transient abnormal myelopoiesis in pediatrics with trisomy 21
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869390/
https://www.ncbi.nlm.nih.gov/pubmed/33598211
http://dx.doi.org/10.1002/ccr3.3589
work_keys_str_mv AT taeenadereh transientabnormalmyelopoiesisinpediatricswithtrisomy21
AT farajigoodarzimojgan transientabnormalmyelopoiesisinpediatricswithtrisomy21
AT safdarimohammad transientabnormalmyelopoiesisinpediatricswithtrisomy21
AT bajelanamir transientabnormalmyelopoiesisinpediatricswithtrisomy21

Ejemplares similares